Clinical Trial Update: T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update examining whether statin use modulates regulatory T cell function to provide a potential benefit in lethal prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Medical University of South Carolina | Conditions: Prostate Cancer | Phase 2 | Status: RECRUITING